Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chenglong Li

Showing results (761-770 of 763) with videos related to

Pageof 77
Sort By:
You have reached the last page of results.This site can display upto 763 results.
Molecular Cell|June 3, 2014
HDAC6 deacetylates and ubiquitinates MSH2 to maintain proper levels of MutSαMu Zhang, Shengyan Xiang, Heui-Yun Joo, et al.
Biomaterials|December 24, 2025
Drug resistant cancer cells show increased nuclear mechanotransduction and mechanically targetable YAP-regulated vulnerabilityMiao Huang, Yinong Chen, Chenyu Liang, et al.
Cancer Research|January 24, 2014
Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastomaFengting Yan, Lapo Alinari, Mark E Lustberg, et al.
Pageof 77

Showing results (761-770 of 763) with videos related to

Sort By:
Pageof 77
You have reached the last page of results.This site can display upto 763 results.
Molecular Cell|June 3, 2014
HDAC6 deacetylates and ubiquitinates MSH2 to maintain proper levels of MutSαMu Zhang, Shengyan Xiang, Heui-Yun Joo, et al.
Biomaterials|December 24, 2025
Drug resistant cancer cells show increased nuclear mechanotransduction and mechanically targetable YAP-regulated vulnerabilityMiao Huang, Yinong Chen, Chenyu Liang, et al.
Cancer Research|January 24, 2014
Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastomaFengting Yan, Lapo Alinari, Mark E Lustberg, et al.
Pageof 77